mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for POLI
Gene summary
Basic gene Info.Gene symbolPOLI
Gene namepolymerase (DNA directed) iota
SynonymsRAD30B|RAD3OB
CytomapUCSC genome browser: 18q21.1
Type of geneprotein-coding
RefGenesNM_007195.2,
DescriptionDNA polymerase iotaRAD30 homolog Beta2polymerase (DNA-directed), iota
Modification date20141207
dbXrefs MIM : 605252
HGNC : HGNC
Ensembl : ENSG00000101751
HPRD : 16094
Vega : OTTHUMG00000132704
ProteinUniProt: Q9UNA4
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_POLI
BioGPS: 11201
PathwayNCI Pathway Interaction Database: POLI
KEGG: POLI
REACTOME: POLI
Pathway Commons: POLI
ContextiHOP: POLI
ligand binding site mutation search in PubMed: POLI
UCL Cancer Institute: POLI
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for POLI
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D331D331GCOAD2
D59V58ECOAD1
T90T90ACOAD1
R372R373QCOAD1
R372R373LLUAD1
R382R382LLUSC1
C336S337LSKCM1
C336S338FSKCM1
S301I300SUCEC1
R372R372HUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for POLI
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
S301I300S-1.6104712
R372R372H-1.3489364
R372R373Q-1.2985245
D331D331G-1.1099451
T90T90A-0.96410007
R372R373L-0.65089202
D59V58E-0.60528555
C336S337L-0.36989182
R382R382L-0.30831395
C336S338F-0.011730854
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for POLI from PDB
PDB IDPDB titlePDB structure
2MBBSolution Structure of the human Polymerase iota UBM1-Ubiquitin Complex

Top
Differential gene expression and gene-gene network for POLI
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of POLI and the right PPI network was created from samples without mutations in the LBS of POLI. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for POLI
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for POLI
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of POLI go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NUCNucleic Acids1t3nAS301
NUCNucleic Acids1zetAS301
NUCNucleic Acids2alzAS301
NUCNucleic Acids2dpiAS301
NUCNucleic Acids2dpjAS301
NUCNucleic Acids2fllAS301
NUCNucleic Acids2flnAS301
NUCNucleic Acids2flpAS301
NUCNucleic Acids3epgAS301
NUCNucleic Acids3epiAS301
NUCNucleic Acids3g6vAS301
NUCNucleic Acids3g6xAS301
NUCNucleic Acids3g6yAS301
NUCNucleic Acids3gv5BS301
NUCNucleic Acids3gv5DS301
NUCNucleic Acids3gv7BS301
NUCNucleic Acids3gv8BS301
NUCNucleic Acids3h40AS301
NUCNucleic Acids3h4bAS301
NUCNucleic Acids3h4dAS301
NUCNucleic Acids3ngdAS301
NUCNucleic Acids3osnAS301
NUCNucleic Acids3q8pBS301
NUCNucleic Acids3q8qBS301
NUCNucleic Acids3q8rBS301
NUCNucleic Acids3q8sBS301
NUCNucleic Acids4ebcAS301
NUCNucleic Acids4ebdAS301
NUCNucleic Acids4ebeAS301
NUCNucleic Acids4eyhBS301
NUCNucleic Acids4eyiBS301
NUCNucleic Acids4fs1AS301
NUCNucleic Acids4fs2AS301


Top
Conservation information for LBS of POLI
Multiple alignments for Q9UNA4 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas